Integrated Diagnostics Holdings ((GB:IDHC)) has held its Q3 earnings call. Read on for the main highlights of the call.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Integrated Diagnostics Holdings (IDH) recently held its earnings call, reflecting a generally positive sentiment with robust growth in revenue and test volumes, particularly in Egypt and Saudi Arabia. The company showcased significant improvements in profitability metrics, although challenges persist in Sudan, and the current contribution from Saudi operations remains minimal.
Strong Revenue Growth
IDH reported an impressive 41% year-on-year revenue growth for the first nine months of 2025. This substantial increase highlights the company’s successful strategies in expanding its market presence and enhancing its service offerings.
Increased Test Volumes and Revenue per Test
The company experienced a 10% increase in test volumes, coupled with a 28% rise in average revenue per test year-on-year. This growth underscores the rising demand for IDH’s diagnostic services and its ability to capitalize on market opportunities.
Expansion in Egypt
IDH expanded its footprint in Egypt by adding 103 new branches, bringing the total to 670 locations. This expansion reinforces Egypt’s position as a core market for the company, contributing significantly to its overall revenue.
Saudi Operations Growth
Revenues in Saudi Arabia more than quadrupled compared to the same period last year, indicating a promising growth trajectory in this market. However, despite this growth, Saudi operations currently contribute less than 1% to the company’s top line.
Profitability Improvements
The company’s EBITDA margin expanded to 35% from 30% last year, and the gross profit margin increased to 43% from 38%. These improvements reflect IDH’s effective cost management and operational efficiencies.
Positive EBITDA in Nigeria
Echo-Lab in Nigeria maintained a positive EBITDA throughout the nine-month period, showcasing the strength and resilience of IDH’s operations in this region.
Challenges in Sudan
Operations in Sudan remain significantly constrained due to ongoing conflict, with only one branch partially operating. This situation poses a challenge to IDH’s otherwise strong performance.
Forward-Looking Guidance
IDH reiterated its full-year guidance, expecting over 35% revenue growth and an EBITDA margin above 30% for 2025. The company plans to continue its geographic expansion, particularly in Egypt, and focus on radiology and specialized diagnostics to drive future growth.
In summary, Integrated Diagnostics Holdings’ earnings call highlighted a strong financial performance with significant revenue growth and improved profitability metrics. While challenges persist in certain regions, the company’s strategic expansions and operational efficiencies position it well for continued success.